king hepatitis C virus
Nature Immunology
November 18, 2013
The mechanism by which variations in the genetic sequence near the gene encoding human interferon lambda (IFNL) are associated with clearance of the hepatitis C virus (HCV) is revealed in a report published online this week in Nature Immunology.
Ram Savan and colleagues found that one particular genetic variant produces more stable IFN-lambda messenger RNA and this leads to increased production of this anti-viral factor. The authors also find HCV tries to ‘escape’ the immune response by aiding in IFN-lambda degradation. Again, the ‘protective’ IFN-lambda variant is more resistant to this degradation process.
The identification of this resistant IFN-lambda variant may explain why certain patients successfully clear HCV following drug treatment whereas a significant minority remain chronically infected.
doi: 10.1038/ni.2758
Research highlights
-
May 12
Geoscience: Monitoring earthquakes at the speed of lightNature
-
May 4
Microbiology: Bacteriophage therapy helps treat multi-drug resistant infection in an immunocompromised patientNature Communications
-
Apr 27
Planetary science: Building blocks of DNA detected in meteoritesNature Communications
-
Apr 8
Health: Psilocybin use associated with lower risk of opioid addictionScientific Reports
-
Apr 5
Energy: Winterizing the Texan energy infrastructure pays off in the long termNature Energy
-
Mar 17
Neuroscience: Sample size matters in studies linking brain scans to behaviourNature